1. Home
  2. MAZE vs XPOF Comparison

MAZE vs XPOF Comparison

Compare MAZE & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAZE
  • XPOF
  • Stock Information
  • Founded
  • MAZE 2018
  • XPOF 2017
  • Country
  • MAZE United States
  • XPOF United States
  • Employees
  • MAZE N/A
  • XPOF N/A
  • Industry
  • MAZE
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • MAZE
  • XPOF Consumer Discretionary
  • Exchange
  • MAZE NYSE
  • XPOF Nasdaq
  • Market Cap
  • MAZE 367.0M
  • XPOF 295.1M
  • IPO Year
  • MAZE 2025
  • XPOF 2021
  • Fundamental
  • Price
  • MAZE $11.74
  • XPOF $7.66
  • Analyst Decision
  • MAZE Strong Buy
  • XPOF Buy
  • Analyst Count
  • MAZE 3
  • XPOF 9
  • Target Price
  • MAZE $25.67
  • XPOF $13.94
  • AVG Volume (30 Days)
  • MAZE 100.1K
  • XPOF 481.1K
  • Earning Date
  • MAZE 08-14-2025
  • XPOF 07-31-2025
  • Dividend Yield
  • MAZE N/A
  • XPOF N/A
  • EPS Growth
  • MAZE N/A
  • XPOF N/A
  • EPS
  • MAZE 0.34
  • XPOF N/A
  • Revenue
  • MAZE $167,500,000.00
  • XPOF $317,536,000.00
  • Revenue This Year
  • MAZE N/A
  • XPOF $1.62
  • Revenue Next Year
  • MAZE N/A
  • XPOF $6.11
  • P/E Ratio
  • MAZE $30.79
  • XPOF N/A
  • Revenue Growth
  • MAZE N/A
  • XPOF N/A
  • 52 Week Low
  • MAZE $6.71
  • XPOF $6.64
  • 52 Week High
  • MAZE $17.00
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • MAZE N/A
  • XPOF 38.86
  • Support Level
  • MAZE N/A
  • XPOF $7.62
  • Resistance Level
  • MAZE N/A
  • XPOF $8.22
  • Average True Range (ATR)
  • MAZE 0.00
  • XPOF 0.41
  • MACD
  • MAZE 0.00
  • XPOF -0.13
  • Stochastic Oscillator
  • MAZE 0.00
  • XPOF 8.08

About MAZE MAZE THERAPEUTICS INC

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: